Nov./Dec. 2019

Letter from the Editor

November 19, 2019

Imagining what’s next… By 2020, it’s estimated that 1.7 megabytes of data will be created every second for every person on earth; 90% of the world’s data has been created in the last two years; healthcare data is doubling every 18 months; 5 billion people around the world lack access to surgeons; 50% of preclinical […]

Upfront

November 19, 2019

Multiple Myeloma Research Foundation’s Endurance Cycling Event The Multiple Myeloma Research Foundation (MMRF), a world-recognized leader in cancer research, has launched the third installment of its annual endurance cycling program, Road to Victories. The Road to Victories Team consists of 30 cyclists, including eight myeloma patients and a myeloma doctor and nurse. The group began […]

HealthTech

November 19, 2019

Apple Research App Allows U.S. Consumers to Participate in Health Studies Trend Watch: Apple, Amazon, Alnylam and Others Explore Digital Health Uses Apple has a new research app for Apple Watch owners that will allow people to opt in to privately contribute to health research by sharing data collected from the smartwatch and its many […]

Artificial Intelligence

November 19, 2019

Novartis and Microsoft Collaborate on AI Lab Trend Watch: AI Partnerships and New Therapeutic Candidates Novartis has founded the Novartis AI innovation lab and is collaborating with Microsoft on the effort. The new lab aims to bolster Novartis AI capabilities from research through commercialization and help accelerate the discovery and development of transformative medicines for […]

Last Word

November 19, 2019

Remaking Clinical Trials with the Patient in Mind Tammy Guld, Global Team Lead for Janssen Clinical Innovation, talks about how the clinical trial experience for patients can be improved. PV: How can pharma companies improve the clinical trial experience for patients and get medicines to market faster? Guld: There is a shift in how patients […]

The Year Ahead…

November 19, 2019

We ask more than 130 experts, what needs to happen to address inefficiency and productivity to achieve aspirational goals for healthcare in the future. For this year’s special 2020 Year in Preview issue, we posed 20 provocative questions to our community of thought leaders, who represent all aspects of the life-sciences industry. We curated responses […]

SHOWCASE: eSolutions: The Digital Future is Here: Technologies Are Driving Change

November 19, 2019

The role of healthcare technology is evolving rapidly. Changing consumer demands and habits and initiatives at a government and industry level are hastening innovation, the adoption of digital health tools, and driving technologies to reach new heights. According to a recent survey conducted by Forbes, 89% of respondents are using at least one digital health […]

Enhancing Patient Engagement Through eClinical Technology

November 19, 2019

The opportunities to strengthen patient engagement across all phases of clinical development have never been greater. Today’s patients are savvy consumers of technology and they expect it to be both easy and enjoyable to use. Study sponsors and clinical research organizations (CROs) should take advantage of the latest tools to ensure that patients’ involvement meets […]

Virtualizing Your Clinical Trials

November 19, 2019

With modern innovation and advances in medical technology, clinical studies and the way they’re conducted are changing. The traditional method of having to travel to a lab, hospital, or test site is inconvenient. Although facility-based studies have consumed the research market for the last century, it should no longer be a mandatory requirement for much […]

Machine Schooling

November 19, 2019

In Douglas Adams’ “The Hitchhiker’s Guide to the Galaxy,” the epoch-spanning artificial intelligence (AI) engine known as Deep Thought wraps its electronic brain around answering the ultimate question of life, the universe, and everything. No one knows what that question is — but I’m imagining healthcare to be at the heart of such a power […]

A Lens Into the Future of Healthcare With Technology-based Solutions

November 19, 2019

In 2015, it became apparent that investors were rapidly pouring money into digital health start-up companies and backing innovators who were eager to stake their claim within the trillion-dollar healthcare industry. In 2019, hardly a day goes by without us hearing about yet another company acquiring funding to “get into healthcare.” The deals are getting […]

SHOWCASE: Supply Chain: A Complex Global Network: Safely Managing the Supply Chain

November 19, 2019

From logistics to storage to tracking and more, the pharmaceutical supply chain is one of the most complex distribution systems of any industry. Most companies lack the efficiencies and equipment needed to deal with the diversity of products in the complex pharmaceutical supply chain. According to a PwC report, pharmaceutical companies will need to rethink […]

Managing Cash Flow and Financial Risk for Cell & Gene Therapies

November 19, 2019

Since the approval of the first CAR-T therapy products in 2017, there has been great excitement around the potential for cell and gene therapies to transform treatment for cancer and other complex diseases. Yet, while optimism is well founded, the journey to make these products available to patients has not been entirely smooth. Despite their […]

Navigating the Cycle of Supply Chain Complexity

November 19, 2019

The pharmaceutical industry’s development and commercialization of innovative new therapies exceeds expectations year after year. It’s truly remarkable to watch these products enter the market and effect real change on patients. As the President of Channel Management at EVERSANA, I’ve had the privilege of working with global manufacturers to strategize and build unique supply chain […]

After Approval, Can Gene Therapies Achieve Marketing Success?

November 19, 2019

Having a well-designed plan that addresses the needs of all stakeholders — patients and their families, medical institutions, payers and manufacturers — will help drive successful outcomes. The advent of gene therapy — personalized medicine reflecting the potential to minimize or cure disease — is an extremely exciting field in disease management. This new frontier […]

The Future of Decentralized Trials

November 19, 2019

Our industry leaders had much to say about patients participating in clinical trials from home, from community sites, virtually — in essence a hybrid of the current system. What would be the impact of siteless trials on clinical development? A provocative question, and one that we posed recognizing that the practical application of clinical trials […]

Real-Time Hope for Rare Diseases

November 19, 2019

With advances in genomics sequencing combined with AI and other tools to speed up data analysis, the potential for quickly diagnosing and ultimately developing therapies that can treat patients with rare diseases in real time grows. The rare diseases space has come on leaps and bounds over the past decade. Advances have been made in […]

Behavioral Science’s Impact on Marketing

November 19, 2019

Behavioral science enables pharma to acquire a greater understanding of its consumers and how to better message them in order to motivate them to change their behavior. Are you a promoter or a preventer? According to the book, “Why We Resist,” written by Syneos Health Communications’ experts Leigh Householder and Kathleen Starr, Ph.D., you will […]

Patient Influencers Are Transforming Pharma Marketing Strategies

November 19, 2019

Companies need to harness the power of social media community influencers — the new healthcare decision makers. Social media provides a huge opportunity for pharma companies to engage with patient leaders and connect to their larger community audiences. Working with advocates and influencers not only yields pertinent insights about what consumers want and need, but […]

The Changing Role of the Traditional Pharma Brand

November 19, 2019

Experts say the industry needs to reinvent its role to create value in diagnostics, prevention, and digital health solutions beyond its traditional brands. According to a Strategy& report out earlier this year, healthcare will be centered on patients who are empowered to prevent diseases rather than seeking treatment by the year 2030. Patients will receive […]

Dr. Robot

November 19, 2019

Robots and docs — automation and clinician. In Disney’s animated hit Big Hero 6, we got a glimpse of what a future of a robot-enabled healthcare future might look like. Disney’s Baymax is an inflatable robot whose sole purpose is to take care of people in everyday life. But real-life medical robots made their debut […]

Wearing Your health: The Case for Smart Clothing

November 19, 2019

As the wearable market continues to expand, the potential for smart clothing to monitor and manage health is breaking new ground. The market for wearables is continuing to grow as more companies enter the space and as more and more consumers acquire devices. According to IDTechEx, the market for wearables was valued at $50 billion […]

Putting Healthcare IoT in the Home

November 19, 2019

The futuristic concept of remote monitoring of patients using the Internet of Things is already here and being used to improve health outcomes. Digitization has become a reality in healthcare, and it’s helping to drive more patient choice, including the ability to manage patient health from the home. Wearable devices and telemedicine allow for remote […]

Patient Care: Treatment to Cure

November 19, 2019

Moving the industry from a focus on treatment to a focus on prevention will require data, new financial incentives, and a change in how healthcare is delivered and paid for. Today, the U.S. healthcare system is a collection of disconnected components: health plans, hospital systems, pharmaceutical companies, medical device manufacturers, and so on. Healthcare consumers […]

Bringing Humanity Back to Healthcare

November 19, 2019

Technology can seem impersonal, but it can also be the driver for enabling more personal connections with patients. From the development of medicines by pharma companies to advancements in treatment protocols to using data to better apply therapeutic regimens, the healthcare industry is committed to using the best scientific and technological developments to improve outcomes. […]

Can Healthcare Be Equitable?

November 19, 2019

Addressing disparities in health is key to achieving progress toward health equity, but in a complex environment how can these goals be achieved? According to the World Health Organization, equity is “the absence of avoidable or remediable differences among groups of people.” From a healthcare perspective, what this means in terms of patient care is […]

Technology Plus Science: New Company Model?

November 19, 2019

We asked a variety of experts what would happen if Apple, Amazon, Google or another big technology company bought a pharma company? Our experts are divided on the likelihood of this happening, but if it did, they say it would be transformational. For more than a decade we have been discussing the role that technology […]

Big Data Requires Big Thinking

November 19, 2019

As more and more data becomes available, the role of the data scientist will rise in the industry. Are data scientists the new superheroes of the future for pharma drug development? That depends on who you ask. The general consensus, however, is that data scientists have the capacity to improve the effectiveness and efficiency of […]

Breaking Down Barriers: Defining Metrics for Diversity & Inclusion

November 19, 2019

It’s become increasingly apparent that D&I metrics need to go beyond numbers of gender and ethnic hires to be meaningful. Diversity and inclusion (D&I) programs are a hot topic for businesses. Across the life-sciences industry, companies have put in place D&I departments to address the gender gap as well as barriers facing people of color. […]

What if Funding Novel Ideas Was More Equitable?

November 19, 2019

Many innovative medicines are in the pipeline. But new funding approaches will be needed to make sure there is a greater chance that they are brought to market. An EvaluatePharma 2018 report suggests an increase in worldwide pharmaceutical R&D spending. Compared with 2016, global R&D spending in 2017 surged by 3.9% to $165 billion. As […]

FEEDBACK